Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Tidbit

Shubham Pandya

Looking forward to reading the results of the subsequent studies

Report an issue with this Tidbit

Back to Tidbits